Quotient Sciences and Biorasi have established a partnership to expedite early phase clinical trials to patient proof of concept (PoC). The collaboration merges Quotient Sciences' early clinical ... Northwell Health has formed a strategic partnership with The START Center for Cancer Research to launch a $5.7 million, 10,000-square-foot early-phase clinical trials center at the Lake Success-based ...
Reuters: Gateway Celebrity Fight Night Delivers an Unforgettable Evening Directly Funding Early-Phase Cancer Research Bryan Adams, David Foster, and others unite for fundraiser, with 100% of money raised directly funding early-phase cancer research ... Gateway Celebrity Fight Night Delivers an Unforgettable Evening Directly Funding Early-Phase Cancer Research Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one agent shown to shrink tumors in patients whose disease had resisted every ... Ophthalmology Times: Ocugen completes dosing early in phase 2/3 GARDian3 trial for Stargardt disease Ocugen completes dosing early in phase 2/3 GARDian3 trial for Stargardt disease Nasdaq: INmune Bio Reports Phase 2 MINDFuL Trial Results for XPro™ in Early Alzheimer’s Disease, Identifying Subpopulations with Cognitive Benefits Phase 2 trial results show XPro™ benefits cognition in certain early Alzheimer's patients, pending further data analysis and FDA designation. INmune Bio Inc.
early phase trials, announced results from its Phase 2 MINDFuL ... INmune Bio Reports Phase 2 MINDFuL Trial Results for XPro™ in Early Alzheimer’s Disease, Identifying Subpopulations with Cognitive Benefits Business Insider: Avance Clinical Appoints Liahna Toy to Lead Global Early Phase Center of Excellence, Advancing Accelerated Early Phase Delivery for Biotechs Avance Clinical Appoints Liahna Toy to Lead Global Early Phase Center of Excellence, Advancing Accelerated Early Phase Delivery for Biotechs
